What is it?
Spravato® is a ketamine-related medication administered as a nasal spray. It works differently in the brain from commonly used antidepressants.
ADMISSIONS 415.945.9870
Review how Spravato® is administered, who may be considered for treatment, and what to expect from care at an approved center.
Spravato® is an FDA-approved treatment for difficult-to-treat depression. This ketamine-related medication is administered as a nasal spray. Treatment must take place at an approved center, where patients are monitored by a clinical team.
Start a treatment inquiryEligibility is assessed individually and includes a review of diagnosis, treatment history, medical considerations, and the required treatment setting.
Spravato® is a ketamine-related medication administered as a nasal spray. It works differently in the brain from commonly used antidepressants.
Spravato® may be considered for people with major depressive disorder who have not responded adequately to multiple antidepressant treatments.
Spravato® must be administered at an approved treatment center. Mind Therapy Clinic is an approved Spravato® center.
Spravato® is administered nasally in a monitored clinical setting. The intake and screening process helps determine whether this treatment and level of care are a reasonable fit.
Our team reviews your diagnosis, medication history, health considerations, and practical requirements for attending treatment consistently.
Treatment takes place in the clinic with required observation and monitoring. The clinical team will explain appointment timing, transportation requirements, and follow-up during the screening process.
Other options may be considered in addition to or instead of Spravato®. Ketamine-Assisted Psychotherapy (KAP) combines ketamine treatment with psychotherapy, preparation, and integration. Transcranial Magnetic Stimulation (TMS) is another noninvasive treatment option.
Review the KAP treatment page or use the inquiry page to review screening considerations for KAP and Spravato®.
Review the treatment and screening considerations before contacting our intake team.